Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Neutrogena Shine Control Makeup
- Manufacturer
- Johnson & Johnson Consumer Inc.
- Effective date
- 2020-05-22
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:28:56
Label at a glance#
ProductNeutrogena Shine Control Makeup Broad Spectrum SPF20 - Classic Ivory 10
Active ingredientTitanium Dioxide
Label structure18 sections
Dosage and administration
For sunscreen use: apply liberally and evenly 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limi...
Storage and handling
protect this product from excessive heat and direct sun may stain some fabrics
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredients
Titanium Dioxide (3.2%)
Purpose
Sunscreen
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away
Directions
For sunscreen use:
- apply liberally and evenly 15 minutes before sun exposure
- reapply at least every 2 hours
- use a water resistant sunscreen if swimming or sweating
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months of age: Ask a doctor
Other Information
- protect this product from excessive heat and direct sun
- may stain some fabrics
Inactive ingredients
Water, Dimethicone, Methyl Trimethicone, Isononyl Isononanoate, C12-15 Alkyl Benzoate, Octyldodecyl Neopentanoate, Lauryl PEG-9 Polydimethylsiloxyethyl Dimethicone, Butylene Glycol, Dimethicone/PEG-10/15 Crosspolymer, Oryza Sativa (Rice) Seed Protein, Dimethicone/Vinyl Dimethicone Crosspolymer, Silica, PEG-9 Polydimethylsiloxyethyl Dimethicone, Sodium Chloride, Glycerin, Acrylates/Dimethicone Copolymer, Phenoxyethanol, Alumina, Caprylyl Glycol, Polyhydroxystearic Acid, Aluminum Stearate, Triethoxycaprylylsilane, Silica Silylate, Disodium EDTA, Sorbic Acid, Titanium Dioxide, Mica, Iron Oxides
Questions or comments?
Visit www. Neutrogena.com or call toll-free 800-480-4812 or 215-273-8755 (collect)
SPL UNCLASSIFIED SECTION
Dist. by Neutrogena Corporation
Los Angeles, CA 90045
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Classic Ivory 10
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Natural Ivory 20
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Buff 30
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Nude 40
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Soft Beige 50
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Natural Beige 60
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Fresh Beige 70
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
PRINCIPAL DISPLAY PANEL - 30 mL Bottle Label - Warm Beige 90
Neutrogena®
shine control
makeup
titanium dioxide sunscreen
broad spectrum
SPF 20
rice protein
complex
1 FL. OZ. (30 mL)
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| Aluminum Stearate | INACTIVE INGREDIENT | U6XF9NP8HM | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Isononyl Isononanoate | INACTIVE INGREDIENT | S4V5BS6GCX | 1 | |
| Methyl Trimethicone | INACTIVE INGREDIENT | S73ZQI0GXM | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Octyldodecyl Neopentanoate | INACTIVE INGREDIENT | X8725R883T | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Rice | INACTIVE INGREDIENT | 659G217HPG | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Classic Ivory 10
- Titanium Dioxide
- Water
- Dimethicone
- Methyl Trimethicone
- Isononyl Isononanoate
- Alkyl (C12-15) Benzoate
- Octyldodecyl Neopentanoate
- Butylene Glycol
- Brown Rice
- Silicon Dioxide
- Sodium Chloride
- Glycerin
- Phenoxyethanol
- Aluminum Oxide
- Caprylyl Glycol
- Aluminum Stearate
- Triethoxycaprylylsilane
- Edetate Disodium
- Sorbic Acid
- Mica
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Natural Ivory 20
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Buff 30
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Nude 40
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Soft Beige 50
- Ferric Oxide Red
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Natural Beige 60
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Fresh Beige 70
- Neutrogena Shine Control Makeup Broad Spectrum SPF20 - Warm Beige 90
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10812-600 | 10812-600-01 |
| 10812-601 | 10812-601-01 |
| 10812-602 | 10812-602-01 |
| 10812-603 | 10812-603-01 |
| 10812-604 | 10812-604-01 |
| 10812-605 | 10812-605-01 |
| 10812-606 | 10812-606-01 |
| 10812-607 | 10812-607-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Aluminum Stearate | ALUMINUM STEARATE | U6XF9NP8HM | OINTMENT / TOPICAL | 0.01 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRAVENOUS | 28773 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION / IONTOPHORESIS | 0.6 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | SOLUTION / OPHTHALMIC | 0.2 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / EPIDURAL | 3535 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / SUBMUCOSAL | 16 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 69 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / INTRACAVITARY | 0.82 %w/v | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, DELAYED RELEASE / ORAL | 14 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | POWDER, FOR SUSPENSION / ORAL | 98 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION, LIPOSOMAL / EPIDURAL | 11 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SYSTEM / TOPICAL | 3.1 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | OINTMENT / TOPICAL | 0.1 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1800 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Aluminum Stearate | ALUMINUM STEARATE | U6XF9NP8HM | TABLET, EXTENDED RELEASE / ORAL | 105 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | GRANULE, FOR SUSPENSION / ORAL | 162 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET / ORAL | 10 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| Aluminum Oxide | ALUMINUM OXIDE | LMI26O6933 | TABLET / ORAL | NA | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, DELAYED RELEASE / ORAL | 3.2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 0.86 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SHAMPOO / TOPICAL | 150 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | CAPSULE, EXTENDED RELEASE / ORAL | 5 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / ORAL | 1126 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 0.68 %w/v | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SOFT TISSUE | 26 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / PARENTERAL | 584 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / BUCCAL | 0.4 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | SUSPENSION / OPHTHALMIC | 10 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SUSPENSION / SUBCUTANEOUS | 0.8 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / DENTAL | 0.4 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / TOPICAL | 1 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | FILM, SOLUBLE / ORAL | 2 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | INJECTION / SUBMUCOSAL | 17 mg | ||
| Sodium Chloride | SODIUM CHLORIDE | 451W47IQ8X | ENEMA / RECTAL | 0.7 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / OPHTHALMIC | 2.5 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, EXTENDED RELEASE / ORAL | 450 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c443030c-0ac3-4938-b424-ca0a36facd1c | 484b16c2-965c-4e41-a43a-54d9a5115c42 | 2020-05-22 | Warnings | c443030c-0ac3-4938-b424-ca0a36facd1c 484b16c2-965c-4e41-a43a-54d9a5115c42 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.